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Summary
Invadopodia are actin-rich subcellular protrusions with as-
sociated proteases used by cancer cells to degrade extracel-
lularmatrix (ECM) [1]. Molecular components of invadopodia
include branched actin-assembly proteins, membrane traf-
ficking proteins, signaling proteins, and transmembrane
proteinases [1]. Similar structures exist in nontransformed
cells, such as osteoclasts and dendritic cells, but are gener-
ally called podosomes and are thought to be more involved
in cell-matrix adhesion than invadopodia [2–4]. Despite inti-
mate contact with their ECM substrates, it is unknown
whether physical or chemical ECM signals regulate invado-
podia function. Here, we report that ECM rigidity directly in-
creases both the number and activity of invadopodia. Trans-
duction of ECM-rigidity signals depends on the cellular
contractile apparatus [5–7], given that inhibition of non-
muscle myosin II, myosin light chain kinase, and Rho kinase
all abrogate invadopodia-associated ECM degradation.
Whereas myosin IIA, IIB, and phosphorylated myosin light
chain do not localize to invadopodia puncta, active phos-
phorylated forms of the mechanosensing proteins p130Cas
(Cas) and focal adhesion kinase (FAK) are present in actively
degrading invadopodia, and the levels of phospho-Cas and
phospho-FAK in invadopodia are sensitive to myosin inhib-
itors. Overexpression of Cas or FAK further enhances inva-
dopodia activity in cells plated on rigid polyacrylamide sub-
strates. Thus, in invasive cells, ECM-rigidity signals lead to
increased matrix-degrading activity at invadopodia, via a
myosin II-FAK/Cas pathway. These data suggest a potential
mechanism, via invadopodia, for the reported correlation of
tissue density with cancer aggressiveness.
Results and Discussion
ECM serves both a signaling and structural role in tissues. In
most cases, ECM is considered to function as a barrier to
cell movements, and in fact degradation by invadopodia con-
stitutes an important mechanism to cross those barriers. How-
ever, when we tested the role of ECM density on invadopodia
function, we unexpectedly found that denser gelatin sub-
strates led to an increase in both the number and ECM-de-
grading capacity of invadopodia (Figure 1). For these studies,
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substrates of 0.5%–5% gelatin coated with FITC-labeled
fibronectin. After 18–20 hr, they were fixed and stained with
rhodamine-labeled phalloidin for identification of actin-rich
invadopodia puncta. As shown in Figure 1, cells cultured on
ECM substrates with a low percentage of gelatin (0.5%) pro-
duced fewer invadopodia and degraded less FN than cells
grown on ECMs with higher percentages of gelatin. The largest
increase in invadopodia number and FN degradation is evident
when the percentage of gelatin is increased from 2.5% to 5%
(Figure 1B). Similar results were seen with FITC-gelatin instead
of FITC-FN/unlabeled gelatin (data not shown).
Increasing the density of the ECM is likely to increase sub-
strate rigidity, which has been shown to affect a variety of
cell functions including migration and cell-lineage specifica-
tion [5–8]. To test whether ECM substrates made with in-
creased gelatin concentrations were more rigid, we measured
viscoelastic properties of gelatin gels on a TA Instruments
AR-G2 rheometer at 37C (Figure 1C). Gels were compressed
between a heated Peltier plate and a 25 mm upper plate and
subjected to an oscillating shear strain. The storage and loss
moduli were measured as a function of frequency, which was
varied from 0.1–10 Hz. The storage modulus is related to the
energy that is stored elastically when the gel is subjected to
a small oscillatory shear deformation. As expected, increasing
the gelatin concentration increases the storage modulus, most
dramatically when the percentage of gelatin is increased from
2.5% to 5% (Figure 1C). These data suggest that rigidity may
play a causative role in promoting invadopodia activity.
In addition to altering ECM rigidity, increasing the gelatin
concentration in invadopodia substrates could increase the
number of integrin ligands. Thus, increased ECM-integrin sig-
naling might promote invadopodia formation and function
through a mechanism that is unrelated to ECM rigidity but
rather due to increased integrin-ligand availability or proximity
[9]. To remove this confounding factor, we cultured cells using
the same conditions as the previous experiment, except for
plating on hard (3300 Pascals) or soft (360 Pascals) polyacryl-
amide (PA) gels that were coated with identical concentrations
of gelatin (1%) and then FITC-Fn. Interestingly, cells cultured
on hard PA gels produce more invadopodia and degrade
more ECM than cells cultured on soft PA gels (Figure 2). Similar
results were seen with FITC-gelatin coating (data not shown),
and coating with gelatin or fibronectin/gelatin has little effect
on the storage modulus of PA gels in rheology experiments
(Figure S1 available online). These data provide strong evi-
dence that ECM rigidity promotes invadopodia formation
and function.
Cells are thought to sense ECM rigidity through integrin-
actomyosin interactions, leading to generation of intracellular
tensile forces through contraction of nonmuscle myosin II
(nm-myosin II) [5, 6]. To test the role of myosin II in invadopodia
function, we added chemical inhibitors of either myosin II
(blebbistatin) or its upstream activator myosin light-chain ki-
nase (ML-7) to cells 2 hr after plating. In either case, inhibition
of myosin II activity results in a dose-dependent decrease in
ECM degradation (Figures 3A and 3B). Inhibition of Rho kinase,
another molecule that promotes cellular contractility through
Figure 1. Increased Density of Gelatin Cushions
Regulates Invadopodia Functions
(A) Wide-field fluorescence images of invadopo-
dia in CA1D cells cultured on FITC-FN/gelatin
cushions with increasing gelatin percentage.
Scale bars represent 10 mm.
(B) Quantification of ECM degradation area/cell
and number of functional invadopodia/cell (actin
puncta associated with degradation sites). Data
are represented as mean 6 standard error (SE);
*p < 0.05, **p < 0.06, compared with 0.5% gelatin.
n = 3.
(C) The storage moduli of gelatin cushions were
measured by rheology, with a TA Instruments
AR-G2 rheometer at 37C and a 25 mm circular
head. The mean values are reported from two
independent experiments performed in triplicate.
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1296effects on myosin light-chain phosphorylation, also prevents
invadopodia-mediated ECM degradation (Figure S2). Interest-
ingly, numerous small puncta that label with the invadopodia
markers actin and cortactin are still present at the ventral sur-
face of inhibitor-treated cells and weakly protrude into the
layer of labeled FN; however, they are smaller and not associ-
ated with ECM degradation (Figures 3A and 3E). Although the
number of total invadopodia (cortactin- and actin-positive
puncta) is variable with inhibitor treatment (red bars, Fig-
ure 3C), the number of functional, ECM-degrading invadopo-
dia (cortactin- and actin-positive puncta with associated
ECM degradation) is consistently decreased with drug treat-
ment (blue bars, Figure 3C). These data suggest that myosin-
based transmission of rigidity signals may promote maturation
rather than formation of invadopodia. We also noticed
changes in mean cell area with blebbistatin and ML-7 treat-
ment; however, the changes were in opposite directions, and
unlike in 2D systems [9], mean cell area did not change signif-
icantly in the invadopodia system with changes in matrix rigid-
ity (Figure S3).
Despite the observed defect in invadopodia maturation and
ECM degradation with inhibitors of myosin II or its upstream
activators, there was no localization of myosin IIA, IIB, or phos-
pho-myosin light chain (pMLC) to invadopodia (Figure S4). In
fact, there was a notable absence of myosin staining within
the puncta. Interestingly, however, in 39.6% of cells myosin
IIA localized in a ring-like structure around invadopodia (Fig-
ure S4A, yellow arrow, see zoom). This localization is reminis-
cent of the rings of adhesion proteins found around actin cores
in podosomes [2, 3]. By contrast, there is either weak or no ap-
parent localization of myosin IIB or pMLC around invadopodia
(Figure S4, red arrows). These data indicate that myosin con-
traction is likely to occur outside of the invadopodia puncta
structure, leading however to increased invadopodia function.
One mechanism that has been identified for transduction of
mechanical forces into signals is mechanosensitive alterations
in the structure of proteins such as p130Cas [10], and poten-
tially focal adhesion kinase (FAK) [11], in response to myosin
II pulling of actin-attached adhesion complexes [12]. Mechan-
ical stretching of p130Cas has been shown to extend the
Figure 2. ECM Rigidity Promotes Invadopodia
Formation and Function
(A) Images of cells cultured on FITC-Fn/1% gela-
tin-coated polyacrylamide (PA) gels with different
rigidities (‘‘Soft’’ or ‘‘Hard’’). Rigidity numbers
reported for PA gels are in kiloPascals (kPa) and
are storage moduli, empirically determined. Ar-
rows point to example invadopodia.
(B) Quantification of invadopodia degradation
area/cell.
(C) Number of F-actin- and cortactin-positive
invadopodia associated with ECM degradation
(‘‘Functional Invadopodia’’) per cell. Data are
represented as mean 6 SE; *p < 0.05. Scale
bars represent 10 mm.
substrate domain, allowing phosphorylation at multiple sites
that are key for integrin signaling pathways [10, 13]. Immunos-
taining with a phosphospecific antibody that recognizes a site
in the Cas substrate domain, pY165, reveals that it is concen-
trated at invadopodia and colocalizes with areas of ECM deg-
radation (Figure 4A). Z section reconstructions indicate that
pY165-Cas is present throughout invadopodial protrusions.
Thus far, a direct effect of mechanical stretching on the molec-
ular conformation of FAK has only been theoretically predicted
from molecular dynamics simulations [11]. However, tyrosine
phosphorylation of focal adhesion kinase (FAK) increases in
cells subjected to mechanical strain [14–16], and a blocking
antibody that targets the autophosphorylation site tyrosine
397 inhibits flow-induced dilatation of coronary arterioles
[17]. Confocal imaging of cells stained with a phosphospecific
antibody against pY397-FAK also reveals staining throughout
invadopodial protrusions (Figure 4B, Z analysis). Between FAK
and Cas, there was a greater tendency to find strong staining
of p130Cas at invadopodia and strong staining of FAK at focal
adhesions (where they occurred), but both molecules were
found in both structures. Immunostaining for total FAK and
Cas also demonstrated localization to invadopodia, albeit
Figure 3. Inhibition of Myosin II Activity Eliminates Invado-
podia-Associated ECM Degradation
(A) Images of CA1D cells treated with the myosin inhibitor
blebbistatin and the MLCK inhibitor ML-7 after plating on
FITC-FN/2.5% gelatin on glass coverslips.
(B) Quantification of the dose-dependent inhibition of ECM
degradation area/cell after treatment with the indicated
doses of blebbistatin or ML-7. Data are represented as
mean 6 SE. Kis were determined by fitting the data with
standard hyperbolic inhibition curves according to the equa-
tion y = constant/(Ki + concentration).
(C) Quantification of the number of total invadopodia (all F-
actin- and cortactin-positive puncta) and functional invado-
podia (F-actin- and cortactin-positive puncta colocalized
with FITC-Fn degradation) in cells treated with 10 mM
blebbistatin or ML-7. *p < 0.05, compared with control cells.
(D) Confocal image of a control cell with invadopodia
degrading FITC-FN/gelatin.
(E) Confocal image of a cell treated with 10 mM blebbistatin.
For (D) and (E), the cell areas within the white boxes were
further imaged with Z section analysis. Note that in blebbis-
tatin-treated cells, the actin puncta are smaller and more
numerous than in control cells and only protrude partially
into the FITC-FN. In addition, unlike in control cells, there is
no ECM degradation associated with actin puncta in bleb-
bistatin-treated cells (white arrow in control FITC-FN Z-stack
points to ECM degradation). Scale bars represent 10 mm for
(A) and 2 mm for (D) and (E).
weaker than that of phosphorylated FAK and
Cas (data not shown).
To test whether the phosphorylation of invado-
podia-localized FAK and Cas can be altered by
contractility, we treated cells with myosin inhibi-
tors and fixed and stained them for actin filaments
and antibodies specific for either pY397-FAK or
pY165-Cas. The intensity of phosphorylated FAK
or Cas was quantitated with a predefined 4 3 4-
pixel-wide box in the center of actively degrading
invadopodia. Consistent with a role in mechano-
sensing, treatment of cells with blebbistatin or
ML-7 led to a significant decrease in the intensity
of phosphorylated FAK and Cas in the few actively
degrading invadopodia that were present (Figure 4C). By con-
trast, in nondegrading actin puncta from the same images,
there was no effect of blebbistatin or ML-7 on phosphoFAK
or phosphoCas intensity compared with DMSO-treated con-
trols (Figure 4C). We also expressed exogenous FAK and
p130Cas in CA1d cells at 3- to 4-fold endogenous levels
(Figure 4D) and found no obvious effect on the expression of
other cell proteins, with the possible exception of aw60 kDa
band in the FAK-OE cells (Figure S5). Interestingly, expression
of either FAK or Cas increases invadopodia-associated degra-
dation in Cas- and FAK-OE cells, compared with that in control
cells, particularly on rigid substrates (Figure 4D). Cas is consis-
tently more robust than FAK in promoting invasiveness, al-
though this may be because of slightly higher expression
levels (Figure 4D). These data are consistent with a role for
FAK and Cas in rigidity-promoted invadopodia activity; future
studies are required to determine the mechanism as well as
the role of FAK and Cas phosphorylation in this process.
Our results indicate that the cellular processes regulating
ECM degradation are instructed by the physics of the sur-
rounding microenvironment. Because nm-myosin II is notice-
ably absent from invadopodial protrusions, contraction does
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not appear to occur within these structures. On the basis of the
presence of phosphorylated forms of the mechanosensing
proteins FAK and p130Cas in invadopodia and the responsive-
ness to myosin inhibitors, we speculate that contractile forces
may be transmitted through cellular actin fibers to invadopodia
to activate these and other mechanosensing proteins. Such
long-range activation of mechanosensing proteins is consis-
tent with a study in which long-range and directional activation
of a src kinase-based FRET reporter occurred in response to
laser tweezer-applied forces on fibronectin-coated beads
[18]. Alternatively, activation of proteins such as FAK and
Cas could occur outside of invadopodia, with subsequent
transport to invadopodia. In addition, we cannot rule out the
possibility of external enhancement of cellular processes,
such as signaling or membrane trafficking, that promote inva-
dopodia activity. Interestingly, myosin IIA sometimes localizes
in a ring around invadopodia, similar to the ring of adhesion
proteins seen around the actin core in podosomes [3]. The
ring or whole-cell population of myosin IIA could provide the
force to transmit rigidity signals from the matrix.
In noninvasive cells, focal adhesions are the primary centers
of mechanotransduction as the point where contractile actin
stress fibers connect with integrins and integrin-associated
signaling proteins such as src kinase, FAK, and p130Cas
[14]. In normal cells that need to remodel ECM or cross tissue
barriers, podosomes are the primary adhesive structures and
contain both focal adhesion and branched actin-assembly
proteins [2, 3]. Invadopodia and podosomes share many
common molecular components; however, the link to adhe-
sion molecules is much less well established for invadopodia
than for podosomes [1–3, 19]. Interestingly, expression of
p130Cas in src-transformed fibroblasts was previously shown
to promote the formation of large ring-like podosome struc-
tures, activation of matrix metalloproteinase 2, invasion
through Matrigel-coated transwell chambers, and experimen-
tal metastasis; however, other noninvasive src-dependent
phenotypes, such as anchorage-independent growth, were
unaffected [20, 21]. These Cas-dependent phenotypes re-
quired intact tyrosine residues in the mechanosensitive
substrate domain [10, 21]. FAK may promote invadopodia for-
mation [22] and has been tied in separate studies to mechano-
sensing [12, 14–17]. In light of our results that ECM rigidity
promotes invadopodia activity, that contractility affects the
phosphorylation of FAK and Cas in invadopodia, and that
Figure 4. The Mechanosensing Signaling Pro-
teins FAK and p130Cas Localize to and Regulate
Invadopodia
(A) Confocal immunofluorescent localization of
actin filaments (actin, blue in merges) and phos-
pho-p130cas (Y165, red in merges) to invadopo-
dia. ECM degradation is evident as dark areas on
the FITC-fibronectin image (FITC-FN, green in
merges). Z section reconstruction shows that
pY165-p130cas (pCas) is present throughout
the invadopodia protrusion and colocalizes to
areas of ECM degradation.
(B) Confocal immunofluorescent localization of
phosphorylated FAK [pFAK (Y397)] to invadopo-
dia. Colors in merges are as in (A). White boxes
in the merged images indicate areas analyzed in
the Z sections.
(C) Quantitation of phosphoFAK (Y397, ‘‘pFAK’’)
and phosphoCas (Y165, ‘‘pCas’’) was performed
by measuring absolute intensity of antibody stain-
ings in a 43 4 pixel box (yellow boxes in zoomed
images show examples) placed in the center of
invadopodia, as defined by punctate actin stain-
ing. Functional invadopodia were defined to have
associated ECM degradation, whereas nonfunc-
tional did not. For (A)–(C), cells were plated on
FITC-Fn overlying 2.5% gelatin. *p < 0.05.
(D) Overexpression of FAK and Cas was achieved
by retroviral transduction of CA1d cells with
LZRS-MS-FAK (LZ-FAK) or LZRS-MS-Cas (LZ-
Cas) vectors, to achieve a 3.1-fold or 3.7-fold
increase in protein expression compared with
vector only (LZ) controls (representative western
blots for total FAK or Cas protein shown, along
with anti-actin western-loading controls). Degra-
dation area per cell was measured on hard or
soft PA gels coated with 1% gelatin/TRITC- or
FITC-Fn, as in Figure 2. Results are presented
as the ratio of degradation area/cell for FAK- or
Cas-overexpressing cells compared with LZRS
controls and show a strong effect on hard PA
gels but only a trend toward increased degrada-
tion with FAK or Cas on soft PA gels. *p < 0.05.
Statistical significance was calculated from raw
data. Error bars were converted as follows: (raw
data SEM/raw data mean) 3 ratio difference.
Scale bars in (A) and (B) represent 10 mm.
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expression of p130Cas and FAK increases invadopodia activ-
ity on rigid substrates, we speculate that in invasive cancer
cells, ECM rigidity may be one important input to p130Cas
and FAK to promote cellular invasion. It is also likely that other
molecules not tested in this study are involved in the invasive
response to ECM rigidity.
In cancer, tumor cells experience increasing tissue rigidity
during tumor development and progression [23–25]. Our data
suggest that one response to rigid tissue environments is up-
regulation of the production and function of invadopodia. In-
deed, increased breast density on mammograms is correlated
with increased risk for invasive behavior of breast cancers,
such that breast-density measurements improve the predic-
tiveness of clinical staging or other prognostic parameters
[26, 27]. Our data complement recent reports demonstrating
altered morphologies and signaling through Rho and Rho ki-
nase of breast epithelial cells in rigid 3D cultures [24, 28] and
provide a novel mechanism of increased invasiveness as
well as indicating potential mechanotransduction targets for
anti-invasive therapies.
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